Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
Recruiting · NCT06273072 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin IN Asthma for Overweight and Obese Individuals (MINA) | Body Weight, Hypersensitivity, Immediate, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Signs and Symptoms, asthma, bronchial disorder, immune system disorder, lung disorder, nutritional disorder, obesity disorder, obstructive lung disease, overnutrition, respiratory system disorder | Recruiting | Phase 2 | 2026-01-16 | NCT06273072 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| Johns Hopkins University | 579 |
| National Heart, Lung, and Blood Institute (NHLBI) | 791 |
| Temple University | 60 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor College of Medicine | Houston | United States | 306 |
| Johns Hopkins University | Baltimore | United States | 25 |